Systemic treatment Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004
Effects of infliximab on systemic features in patients with COPD suffering from cachexia Source: Eur Respir J 2006; 28: Suppl. 50, 105s Year: 2006
Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Isophonum usage in treatment of patients with pulmonary tuberculosis and accompanying pathology and elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Systemic inflammatory response during one year follow-up in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Systemic antioxidant status in Chinese patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 509s Year: 2004
Diagnosis and treatment of COPD patients who respond to steroids Source: International Congress 2017 – State of the art session: "Airway diseases" Year: 2017
Prevalence of lupus anticoagulant in patients undergoing bronchoscopy Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
Management of recurrent PE in patients on anticoagulant therapy Source: Virtual Congress 2021 – Pulmonary embolism: special situations Year: 2021
Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002
Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018 Year: 2018
Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
Efficacy of traditional and combined therapy in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003
Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018 Year: 2019
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
Efficacy of oral add-on therapy in patients with pulmonary hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009